Home600664 • SHA
add
Harbin Pharmaceutical Group Co., Ltd.
Nakaraang pagsara
¥3.81
Sakop ng araw
¥3.79 - ¥3.87
Sakop ng taon
¥2.41 - ¥4.26
Market cap
9.52B CNY
Average na Volume
47.50M
P/E ratio
15.92
Dividend yield
-
Primary exchange
SHA
Mga balita tungkol sa merkado
Mga Financial
Income Statement
Kita
Net na kita
| (CNY) | Set 2024info | Y/Y na pagbabago |
|---|---|---|
Kita | 4.11B | 8.54% |
Gastos sa pagpapatakbo | 833.10M | 0.85% |
Net na kita | 164.90M | 52.98% |
Net profit margin | 4.01 | 41.20% |
Kita sa bawat share | — | — |
EBITDA | 318.87M | 26.26% |
Aktuwal na % ng binabayarang buwis | 23.46% | — |
Balance Sheet
Kabuuang asset
Kabuuang sagutin
| (CNY) | Set 2024info | Y/Y na pagbabago |
|---|---|---|
Cash at mga panandaliang investment | 3.13B | 13.03% |
Kabuuang asset | 14.27B | 2.51% |
Kabuuang sagutin | 8.32B | -3.45% |
Kabuuang equity | 5.95B | — |
Natitirang share | 2.52B | — |
Presyo para makapag-book | 1.84 | — |
Return on assets | 4.51% | — |
Return on capital | 8.25% | — |
Cash Flow
Net change in cash
| (CNY) | Set 2024info | Y/Y na pagbabago |
|---|---|---|
Net na kita | 164.90M | 52.98% |
Cash mula sa mga operasyon | 105.03M | -61.67% |
Cash mula sa pag-invest | -35.33M | 74.29% |
Cash mula sa financing | -173.45M | -5,358.43% |
Net change in cash | -104.01M | -174.49% |
Malayang cash flow | -77.99M | 22.01% |
Tungkol
Harbin Pharmaceutical Group Co., Ltd. is a Chinese partially state-owned company engaged in the research & development, manufacture, and sale of pharmaceutical products. HPGC medication offerings include traditional Chinese medicine and biopharmaceuticals; its main offerings include antibiotics, including amoxicillin and penicillin, and dietary supplements, including zinc gluconate and calcium gluconate.
The company owns both Renmintongtai, a drugstore chain and medical wholesaler for the domestic market, and GNC, a U.S.-based international retailer of supplements and wellness products. Wikipedia
Itinatag
1988
Website
Mga Empleyado
9,853
